Kirk McDonald Net Worth

Kirk McDonald biography

Kirk McDonald serves as Independent Director of the Company. Mr. McDonald has served as the Chief Business Officer of Xandr, AT&T’s advertising company, since September 2019, and from 2017, has served as Xandr’s the Chief Marketing Officer. Prior to Xandr, from 2011 to 2017, Mr. McDonald served as the President of PubMatic, a company developing and implementing online advertising software and strategies. Before joining PubMatic, he was President of Digital at Time Inc., from 2009 to 2011, and the Chief Advertising Officer of the Fortune|Money Group. He has also served as the SVP of Sales, Marketing and Client Services for DRIVEpm and Atlas, both units of Microsoft’s advertising business, as well as in various roles at CNET, Ziff Davis and Condé Nast. McDonald serves on several professional and not-for-profit boards. He was a former advisor on the LUMA Partners board and is currently the Chairman of a non-profit, Code Interactive, which is focused on inspiring the next generation of technology leaders from underserved communities.

What is the salary of Kirk McDonald?

As the Independent Director of Elanco Animal Health Inc, the total compensation of Kirk McDonald at Elanco Animal Health Inc is $293,342. There are 13 executives at Elanco Animal Health Inc getting paid more, with Jeffrey Simmons having the highest compensation of $15,801,800.

What's Kirk McDonald's mailing address?

Kirk's mailing address filed with the SEC is C/O ELANCO ANIMAL HEALTH INCORPORATED, 2500 INNOVATION WAY, GREENFIELD, IN, 46140.

Insiders trading at Elanco Animal Health Inc

Over the last 6 years, insiders at Elanco Animal Health Inc have traded over $1,626,280,000 worth of Elanco Animal Health Inc stock and bought 657,104 units worth $14,225,149 . The most active insiders traders include Aktiengesellschaft Bayer Wo..., Scott D.Sachem Head Capital... и R David Hoover. On average, Elanco Animal Health Inc executives and independent directors trade stock every 38 days with the average trade being worth of $14,011,833. The most recent stock trade was executed by Michael J Harrington on 22 August 2024, trading 3,500 units of ELAN stock currently worth $51,975.

What does Elanco Animal Health Inc do?

elanco is a global animal health company. our vision: food and companionship enriching life. elanco fulfills this vision through three primary pursuits: - helping deliver a safe, more affordable, more abundant food supply by improving the health and performance of animals - helping pets live longer, healthier, higher-quality lives - improving food safety elanco employees are empowered to preserve elanco’s common culture of humility, discipline and involvement. we have a responsibility to connect and contribute to our cause, to be passionate about delivering solutions and value to our customers, and to embrace opportunities for personal and professional growth and development. through innovative products, quality systems and a shared vision, elanco strives daily to enhance animal health—and enrich the lives of people worldwide.

Elanco Animal Health Inc executives and stock owners

Elanco Animal Health Inc executives and other stock owners filed with the SEC include:

• Jeffrey Simmons,
  President, Chief Executive Officer, Director
• Sarena Lin,
  Executive Vice President, Global Marketing, Corporate Strategy and Transformation
• David Kinard,
  Executive Vice President of Human Resources
• David Urbanek,
  Executive Vice President - Manufacturing, Quality
• Aaron Schacht,
  Executive Vice President - Innovation, Regulatory, Business Development
• Todd Young,
  Chief Financial Officer, Executive Vice President
• Jeffrey N. Simmons,
  Pres, CEO & Director
• Todd S. Young,
  Exec. VP of Corp. Governance and Strategy & CFO
• R. David Hoover,
  Independent Chairman of the Board
• Kapila Anand,
  Independent Director
• Lawrence Kurzius,
  Independent Director
• Michael Harrington,
  Independent Director
• John Bilbrey,
  Independent Director
• Denise Scots-Knight,
  Independent Director
• Kirk McDonald,
  Independent Director
• Deborah Kochevar,
  Independent Director
• Art Garcia,
  Independent Director
• Joshua Smiley,
  Independent Director
• Aarti Shah,
  Independent Director
• David Ricks,
  Independent Director
• Carl McMillian,
  Independent Director
• James Meer,
  Chief Accounting Officer, Vice President
• Ramiro Cabral,
  Executive Vice President - Elanco International
• Michael-Bryant Hicks,
  Executive Vice President, General Counsel, Corporate Secretary
• Larbi Van Lier,
  Sr. VP of Asia
• Shawn McKee,
  Sr. VP of U.S. Companion Animal
• David Alan Urbanek,
  Exec. VP of Manufacturing & Quality
• Ramiro Martin Cabral,
  Exec. VP of Elanco International
• Racquel Harris Mason,
  Exec. VP & Chief Marketing Officer
• Marcela A. Kirberger,
  Exec. VP, Gen. Counsel & Corp. Sec.
• Tiffany Ann Kanaga,
  Head of Investor Relations
• David S. Kinard,
  Exec. VP of HR Corp. Affairs & Admin.
• Chris Keeley,
  Sr. VP & Chief Information Officer
• James M. Meer,
  VP & Chief Accounting Officer
• De Simas Jose Manuel Correia,
  SEE REMARKS
• Lilly & Co Eli,
  10% owner
• Timothy J Bettington,
  SEE REMARKS
• Aktiengesellschaft Bayer Wo...,
  
• Racquel Harris Mason,
  See Remarks
• Dirk Ehle,
  Ex VP & Pres Elanco Europe
• Joyce J. Lee,
  Ex VP Prs US Pet Hlth Com Op
• Rajeev A. Modi,
  SEE REMARKS
• Paul Herendeen,
  
• Marcela A. Kirberger,
  SEE REMARKS
• William F Doyle,
  
• Scott D.Sachem Head Capital...,
  
• Brabander Ellen De,
  SEE REMARKS
• Shiv O'neill,
  GC AND CORP SEC
• Grace Mc Ardle,
  EVP, MANUFACTURING AND QUALITY